Article info
PDFInflammatory bowel disease
Original article
Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD
- Correspondence to Professor Dirk Haller, Chair of Nutrition and Immunology, Technische Universität München, Gregor-Mendel-Str. 2, Freising 85354, Germany; dirk.haller{at}tum.de
Citation
Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD
Publication history
- Received May 9, 2015
- Revised December 2, 2015
- Accepted December 21, 2015
- First published February 4, 2016.
Online issue publication
October 26, 2017
Article Versions
- Previous version (26 October 2017).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
- Data supplement 1 - Online supplement
- Data supplement 2 - Online figure
- Data supplement 3 - Online tables
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/